相似文献
1
The case for chemotherapy alone for limited-stage Hodgkin's lymphoma.
Oncologist. 2012;17(8):1011-3. doi: 10.1634/theoncologist.2012-0228. Epub 2012 Jul 17.
2
The case for combined-modality therapy for limited-stage Hodgkin's disease.
Oncologist. 2012;17(8):1006-10. doi: 10.1634/theoncologist.2012-0148. Epub 2012 Jul 17.
3
Early, intermediate and advanced Hodgkin's lymphoma: modern treatment strategies.
Ann Oncol. 2007 Jul;18 Suppl 9:ix71-9. doi: 10.1093/annonc/mdm297.
4
Treatment of Stage IIIa Hodgkin's disease: long follow-up perspective.
J Clin Oncol. 2008 Nov 10;26(32):5144-6. doi: 10.1200/JCO.2008.19.0330. Epub 2008 Oct 14.
5
Doxorubicin, bleomycin, vinblastine, and dacarbazine alone in treatment of favorable, limited-stage Hodgkin's lymphoma: do we really have robust data?
J Clin Oncol. 2010 Sep 20;28(27):e485-6; author reply e487. doi: 10.1200/JCO.2010.29.0304. Epub 2010 Jul 6.
6
New strategies for the treatment of early stages of Hodgkin's lymphoma.
Hematol Oncol Clin North Am. 2007 Oct;21(5):871-80. doi: 10.1016/j.hoc.2007.06.014.
7
Substaging of stage III Hodgkin's disease.
Hematol Oncol Clin North Am. 1989 Jun;3(2):277-86.
8
[Hodgkin's disease 1986].
Med Clin (Barc). 1987 Feb 7;88(5):188-91.
9
ABVD alone versus radiation-based therapy in limited-stage Hodgkin's lymphoma.
N Engl J Med. 2012 Feb 2;366(5):399-408. doi: 10.1056/NEJMoa1111961. Epub 2011 Dec 11.
10
Limited field radiotherapy for early stage, infra-diaphragmatic Hodgkin's lymphoma.
Clin Oncol (R Coll Radiol). 2004 Feb;16(1):53-7. doi: 10.1016/j.clon.2003.08.007.
引用本文的文献
1
Omitting or reducing radiotherapy in childhood or adolescence Hodgkin Lymphoma.
Transl Pediatr. 2013 Jul;2(3):126-30. doi: 10.3978/j.issn.2224-4336.2013.06.03.
本文引用的文献
1
The case for combined-modality therapy for limited-stage Hodgkin's disease.
Oncologist. 2012;17(8):1006-10. doi: 10.1634/theoncologist.2012-0148. Epub 2012 Jul 17.
2
Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin's lymphoma.
J Clin Oncol. 2012 Jun 20;30(18):2183-9. doi: 10.1200/JCO.2011.38.0410. Epub 2012 Mar 26.
3
ABVD alone versus radiation-based therapy in limited-stage Hodgkin's lymphoma.
N Engl J Med. 2012 Feb 2;366(5):399-408. doi: 10.1056/NEJMoa1111961. Epub 2011 Dec 11.
4
Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma.
N Engl J Med. 2010 Aug 12;363(7):640-52. doi: 10.1056/NEJMoa1000067.
5
Tumor-associated macrophages and survival in classic Hodgkin's lymphoma.
N Engl J Med. 2010 Mar 11;362(10):875-85. doi: 10.1056/NEJMoa0905680.
6
Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.
J Clin Oncol. 2003 Feb 15;21(4):607-14. doi: 10.1200/JCO.2003.12.086.
7
Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP.
Cancer. 1975 Jul;36(1):252-9. doi: 10.1002/1097-0142(197507)36:1<252::aid-cncr2820360128>3.0.co;2-7.
Zotero 插件